Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural requirements for cannabinoid receptor probes.

G A Thakur1, S P Nikas, C Li

  • 1Center for Drug Discovery, Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.

Handbook of Experimental Pharmacology
|April 7, 2006
PubMed
Summary

Researchers explored the structural needs of cannabinoid receptor ligands, including reversible and irreversible probes. This research illuminates the pharmacological and therapeutic potential of these compounds for future drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.

British journal of pharmacology·2018
Same author

In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.

Neurogastroenterology and motility·2015
Same author

Medicinal chemistry of cannabinoids.

Clinical pharmacology and therapeutics·2015
Same author

AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.

British journal of pharmacology·2015
Same author

Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme.

British journal of pharmacology·2014
Same author

Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.

British journal of pharmacology·2013

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Discovery of CB1 and CB2 cannabinoid receptors and endogenous ligands like anandamide and 2-AG has advanced cannabinoid biology.
  • Numerous synthetic cannabinoid analogs have been developed, offering insights into receptor binding and activation.

Purpose of the Study:

  • To review the structural requirements for cannabinoid receptor ligands.
  • To highlight the pharmacological and therapeutic potential of these ligands.

Main Methods:

  • Review of existing literature on cannabinoid receptor ligands.
  • Analysis of structure-activity relationships for diverse cannabinoid analogs.
  • Discussion of molecular modeling and site-directed mutagenesis studies.

Related Experiment Videos

Main Results:

  • Diverse classes of cannabinoid ligands interact with receptors via distinct binding motifs.
  • Molecular probes are crucial for elucidating exact binding sites.
  • Ligands can be reversible or irreversible, forming covalent bonds.

Conclusions:

  • Understanding ligand structure is key to cannabinoid receptor targeting.
  • Cannabinoid receptor ligands possess significant pharmacological and therapeutic promise.